1. Home
  2. CCD vs DNA Comparison

CCD vs DNA Comparison

Compare CCD & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Calamos Dynamic Convertible & Income Fund

CCD

Calamos Dynamic Convertible & Income Fund

HOLD

Current Price

$21.86

Market Cap

579.8M

Sector

Finance

ML Signal

HOLD

Logo Ginkgo Bioworks Holdings Inc.

DNA

Ginkgo Bioworks Holdings Inc.

HOLD

Current Price

$9.68

Market Cap

562.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCD
DNA
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
579.8M
562.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CCD
DNA
Price
$21.86
$9.68
Analyst Decision
Strong Sell
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
96.1K
1.0M
Earning Date
01-01-0001
02-24-2026
Dividend Yield
10.61%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$180,606,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.93
$5.00
52 Week High
$24.68
$17.58

Technical Indicators

Market Signals
Indicator
CCD
DNA
Relative Strength Index (RSI) 59.87 59.50
Support Level $20.80 $8.08
Resistance Level $21.71 $9.12
Average True Range (ATR) 0.34 0.51
MACD 0.06 0.17
Stochastic Oscillator 95.71 94.61

Price Performance

Historical Comparison
CCD
DNA

About CCD Calamos Dynamic Convertible & Income Fund

Calamos Dynamic Convertible and Income Fund operates as a diversified, closed-end management investment company. The fund's investment objective is to provide total return through a combination of current income and capital appreciation. It predominantly invests in a portfolio of convertible securities, investment grade and below investment grade bonds, loans, equity-linked notes, and floating rate securities.

About DNA Ginkgo Bioworks Holdings Inc.

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Share on Social Networks: